Yogesh Patel

ORCID: 0000-0002-8916-5228 · 2 papers in corpus

rct 2024

Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study

BMJ open ·doi:10.1136/bmjopen-2024-087431

OBJECTIVE: Pregnant women with COVID-19 are at elevated risk for severe outcomes, but clinical data on management of these patients are limited. Monoclonal antibodies, such as casirivimab plus imdevimab (CAS+IMD), have proven effective in t…

observational 1989

Coexistence of polycystic ovary syndrome and pelvic endometriosis

Obstetrics and gynecology

Pelvic endometriosis was observed in 15 of 91 women (16.5%) with laparoscopically confirmed polycystic ovary syndrome. There were no significant clinical differences among those with and those without endometriosis. The groups were of simil…